Stay updated on VinMetAtezo: Stage IV NSCLC Clinical Trial

Sign up to get notified when there's something new on the VinMetAtezo: Stage IV NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the VinMetAtezo: Stage IV NSCLC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page now displays the clinical trial record, including its treatment plan, eligibility criteria, study locations, outcome measures, publications, and data-sharing details, instead of a 403 error.
    Difference
    53%
    Check dated 2026-11-09T13:23:23.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0 while the page continued to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T13:24:36.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    A notice announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs. It appears above the unavailable study record.
    Difference
    1%
    Check dated 2026-10-26T15:53:32.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer revision label was updated from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T15:52:35.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The site revision marker changed from v3.7.0 to v3.7.1 on the error page.
    Difference
    0.2%
    Check dated 2026-10-12T15:48:47.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error, replacing the previous content and navigation with a minimal error view, which renders the VinMetAtezo trial information inaccessible.
    Difference
    18%
    Check dated 2026-09-21T20:33:05.000Z thumbnail image

Stay in the know with updates to VinMetAtezo: Stage IV NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the VinMetAtezo: Stage IV NSCLC Clinical Trial page.